Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proinvesa Group is an Argentine diversified holding group with activities spanning animal biotechnology, veterinary products, biopharmaceutical development, genetics, ranching, wine, and real estate. Its life-science activities appear to center on cloning, gene banking, stem cells, molecular biology, bovine reproductive technologies, and a biopharmaceutical startup focused on complex biological products for human pharmaceutical use. Publicly available information also links the group to Kheiron Biotech, described as a Proinvesa Group company involved in precision breeding and gene-editing projects in cattle. The group appears to operate more as a parent organization and innovation platform than as a single-product clinical biotech, and there is no clear evidence of an advanced human therapeutic pipeline or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proinvesa Group.